DBD 9.30.2013 10Q
Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 
__________________________________________________
Form 10-Q
__________________________________________________ 
x
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2013
OR
o
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                      to                     
Commission file number 1-4879 
_________________________________________________
Diebold, Incorporated
(Exact name of registrant as specified in its charter)
_________________________________________________ 
Ohio
 
34-0183970
(State or other jurisdiction of
incorporation or organization)
 
(IRS Employer
Identification Number)
 
 
 
5995 Mayfair Road, PO Box 3077, North Canton, Ohio
 
44720-8077
(Address of principal executive offices)
 
(Zip Code)
Registrant’s telephone number, including area code: (330) 490-4000
__________________________________________________ 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x     No  o
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  x    No  o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
x
Accelerated filer
o
Non-accelerated filer
(Do not check if a smaller reporting company)
o
Smaller reporting company
o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  o    No  x
Number of shares of common stock outstanding as of October 31, 2013 was 63,838,305.


Table of Contents

DIEBOLD, INCORPORATED AND SUBSIDIARIES
FORM 10-Q

INDEX
 
PART II – OTHER INFORMATION
ITEM 1A: RISK FACTORS
ITEM 6: EXHIBITS


Table of Contents

PART I – FINANCIAL INFORMATION

ITEM 1: FINANCIAL STATEMENTS
DIEBOLD, INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(dollars in thousands)
 
 
September 30,
2013

December 31,
2012
 
 
(Unaudited)
 
 
ASSETS
 
 
 
 
Current assets
 
 
 
 
Cash and cash equivalents

$
205,921


$
368,792

Short-term investments

199,703


261,886

Trade receivables, less allowances for doubtful accounts of $25,560 and $27,854, respectively
 
515,703

 
488,373

Inventories
 
480,420

 
412,996

Deferred income taxes
 
109,560

 
143,248

Prepaid expenses
 
23,544

 
35,614

Prepaid income taxes
 
37,344

 
16,357

Other current assets
 
134,038

 
87,591

Total current assets
 
1,706,233

 
1,814,857

Securities and other investments
 
76,865

 
77,101

Property, plant and equipment, at cost
 
603,699

 
661,910

Less accumulated depreciation and amortization
 
439,558

 
477,565

Property, plant and equipment, net
 
164,141

 
184,345

Goodwill
 
182,862

 
272,951

Deferred income taxes
 
11,002

 
76,375

Other assets
 
158,634

 
167,358

Total assets
 
$
2,299,737

 
$
2,592,987

LIABILITIES AND EQUITY
 
 
 
 
Current liabilities
 
 
 
 
Notes payable
 
$
26,773

 
$
34,212

Accounts payable
 
210,472

 
224,973

Deferred revenue
 
224,182

 
222,343

Payroll and other benefits liabilities
 
76,436

 
69,814

Other current liabilities
 
362,038

 
306,002

Total current liabilities
 
899,901

 
857,344

Long-term debt
 
561,595

 
617,534

Pensions and other benefits
 
76,318

 
198,241

Post-retirement and other benefits
 
23,229

 
22,904

Deferred income taxes
 
20,863

 
34,250

Other long-term liabilities
 
40,173

 
35,892

Commitments and contingencies
 

 

Equity
 
 
 
 
Diebold, Incorporated shareholders' equity
 
 
 
 
Preferred shares, no par value, 1,000,000 authorized shares, none issued
 

 

Common shares, $1.25 par value, 125,000,000 authorized shares, 78,376,572 and 77,661,118 issued shares, 63,838,305 and 63,240,667 outstanding shares, respectively
 
97,971

 
97,076

Additional capital
 
381,720

 
358,281

Retained earnings
 
782,705

 
978,345

Treasury shares, at cost (14,538,267 and 14,420,451 shares, respectively)
 
(554,849
)
 
(551,189
)
Accumulated other comprehensive loss
 
(50,913
)
 
(91,039
)
Total Diebold, Incorporated shareholders' equity
 
656,634

 
791,474

Noncontrolling interests
 
21,024

 
35,348

Total equity
 
677,658

 
826,822

Total liabilities and equity
 
$
2,299,737

 
$
2,592,987

See accompanying notes to condensed consolidated financial statements.

3

Table of Contents

DIEBOLD, INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(unaudited)
(in thousands, except per share amounts)
 

 
 
Three Months Ended
 
Nine Months Ended
 
 
September 30,
 
September 30,
 
 
2013
 
2012
 
2013
 
2012
Net sales
 
 
 
 
 
 
 
 
Services
 
$
405,238

 
$
402,305

 
$
1,200,672

 
$
1,196,079

Products
 
300,186

 
307,614

 
845,376

 
955,519

 
 
705,424

 
709,919

 
2,046,048


2,151,598

Cost of sales
 
 
 
 
 
 
 
 
Services
 
290,121

 
301,787

 
904,167

 
881,275

Products
 
242,498

 
236,555

 
681,646

 
723,203

 
 
532,619

 
538,342

 
1,585,813

 
1,604,478

Gross profit
 
172,805

 
171,577

 
460,235

 
547,120

Selling and administrative expense
 
111,683


120,892

 
394,401

 
359,450

Research, development and engineering expense
 
21,957


22,167

 
66,404

 
61,140

Impairment of assets
 
70,000


7,930

 
70,642

 
14,631

Gain on sale of assets, net
 
(582
)
 
(437
)
 
(3,421
)
 
(397
)
 
 
203,058

 
150,552

 
528,026

 
434,824

Operating (loss) profit
 
(30,253
)
 
21,025

 
(67,791
)

112,296

Other income (expense)
 
 
 
 
 
 
 
 
Investment income
 
6,695

 
9,298

 
21,060

 
29,292

Interest expense
 
(7,918
)
 
(7,615
)
 
(22,027
)
 
(22,684
)
Foreign exchange gain (loss), net
 
2,977

 
930

 
(1,453
)
 
2,577

Miscellaneous, net
 
355

 
607

 
(434
)
 
948

(Loss) income before taxes
 
(28,144
)
 
24,245

 
(70,645
)
 
122,429

Income tax expense
 
(7,940
)
 
7,394

 
67,293

 
34,246

Net (loss) income
 
(20,204
)
 
16,851

 
(137,938
)
 
88,183

Net income attributable to noncontrolling interests
 
1,486

 
630

 
2,233

 
2,722

Net (loss) income attributable to Diebold, Incorporated
 
$
(21,690
)
 
$
16,221

 
$
(140,171
)
 
$
85,461

 
 
 
 
 
 
 
 
 
Basic weighted-average shares outstanding
 
63,825

 
63,211

 
63,648

 
63,003

Diluted weighted-average shares outstanding
 
63,825

 
64,134

 
63,648

 
63,930

 
 
 
 
 
 
 
 
 
Net (loss) income attributable to Diebold, Incorporated:
 
 
 
 
 
 
 
 
Basic (loss) earnings per share
 
$
(0.34
)
 
$
0.26

 
$
(2.20
)
 
$
1.36

Diluted (loss) earnings per share
 
$
(0.34
)
 
$
0.25

 
$
(2.20
)
 
$
1.34

See accompanying notes to condensed consolidated financial statements.


4

Table of Contents

DIEBOLD, INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(unaudited)
(in thousands)

 
 
Three Months Ended
 
Nine Months Ended
 
 
September 30,
 
September 30,
 
 
2013
 
2012
 
2013
 
2012
Net (loss) income
 
$
(20,204
)
 
$
16,851

 
$
(137,938
)
 
$
88,183

Other comprehensive income (loss), net of tax:
 
 
 
 
 
 
 
 
Translation adjustment
 
(6,269
)
 
2,878

 
(52,771
)
 
(37,460
)
Foreign currency hedges
 
(445
)
 
1,936

 
2,223

 
1,806

Interest rate hedges:
 


 


 
 
 
 
Net gain (loss) recognized in other comprehensive income
 
66

 
(133
)
 
608

 
(64
)
Less: reclassification adjustment for net gains
 
48

 
82

 
159

 
252

 
 
18

 
(215
)
 
449

 
(316
)
Pension and other post-retirement benefits:
 
 
 
 
 
 
 
 
Net actuarial loss amortization
 
1,940

 
4,330

 
8,875

 
12,967

Net prior service benefit amortization
 
(171
)
 
(65
)
 
(301
)
 
(194
)
Net actuarial gain occurring during the period (note 11)
 
45,539

 

 
45,539

 

Curtailment (note 11)
 
34,558

 

 
35,257

 

 
 
81,866

 
4,265

 
89,370

 
12,773

Unrealized gain (loss) on securities, net:
 
 
 
 
 
 
 
 
Net gain recognized in other comprehensive income
 
277

 
132

 
2,327

 
3,049

Less: reclassification adjustment for net gains
 
1,012

 
1,728

 
1,139

 
3,236

 
 
(735
)
 
(1,596
)
 
1,188

 
(187
)
Other
 
8

 
2

 
22

 
12

Other comprehensive income (loss), net of tax
 
74,443

 
7,270

 
40,481

 
(23,372
)
Comprehensive income (loss)
 
54,239

 
24,121

 
(97,457
)
 
64,811

Less: comprehensive income attributable to noncontrolling interests
 
1,507

 
944

 
2,588

 
2,806

Comprehensive income (loss) attributable to Diebold, Incorporated
 
$
52,732

 
$
23,177

 
$
(100,045
)
 
$
62,005

See accompanying notes to condensed consolidated financial statements.

5

Table of Contents

DIEBOLD, INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(unaudited)
(in thousands)
 
 
 
Nine Months Ended
 
 
September 30,
 
 
2013
 
2012
Cash flow from operating activities:
 
 
 
 
Net (loss) income
 
$
(137,938
)
 
$
88,183

Adjustments to reconcile net (loss) income to cash flow used in operating activities:
 
 
 
 
Depreciation and amortization
 
64,085

 
56,909

Share-based compensation
 
14,070

 
9,860

Excess tax benefits from share-based compensation
 
(378
)
 
(1,705
)
Devaluation of Venezuelan balance sheet
 
1,584

 

Gain on sale of assets, net
 
(3,421
)
 
(397
)
Impairment of assets
 
70,642

 
14,631

Equity in earnings of an investee
 

 
(702
)
Cash flow from changes in certain assets and liabilities:
 
 
 
 
Trade receivables
 
(41,789
)
 
(49,683
)
Inventories
 
(79,492
)
 
(55,397
)
Prepaid expenses
 
11,481

 
(1,698
)
Prepaid income taxes
 
(20,987
)
 
3,823

Other current assets
 
(42,544
)
 
(28,049
)
Accounts payable
 
(10,660
)
 
(2,013
)
Deferred revenue
 
5,168

 
(34,053
)
Deferred income tax
 
40,164

 
2,480

Certain other assets and liabilities
 
70,973

 
(30,945
)
Net cash used in operating activities
 
(59,042
)
 
(28,756
)
Cash flow from investing activities:
 
 
 
 
Payments for acquisitions, net of cash acquired
 

 
(23,625
)
Proceeds from maturities of investments
 
379,889

 
261,817

Proceeds from sale of investments
 
22,711

 
33,437

Payments for purchases of investments
 
(363,710
)
 
(299,265
)
Proceeds from sale of assets
 
4,353

 
1,851

Capital expenditures
 
(25,648
)
 
(35,856
)
Collections on purchased finance receivables
 
6,105

 
12,296

Increase in certain other assets
 
(10,006
)
 
(9,105
)
Net cash provided by (used in) investing activities
 
13,694

 
(58,450
)
Cash flow from financing activities:
 
 
 
 
Dividends paid
 
(55,469
)
 
(54,573
)
Revolving debt borrowings, net
 
11,007

 
139,000

Other debt borrowings
 
38,591

 
94,602

Other debt repayments
 
(112,140
)
 
(139,269
)
Distributions of affiliates earnings to noncontrolling interest holders
 
(6,380
)
 
(2,092
)
Excess tax benefits from share-based compensation
 
378

 
1,705

Issuance of common shares
 
10,264

 
16,651

Repurchase of common shares
 
(3,660
)
 
(3,076
)
Net cash (used in) provided by financing activities
 
(117,409
)
 
52,948

Effect of exchange rate changes on cash and cash equivalents
 
(114
)
 
2,888

Decrease in cash and cash equivalents
 
(162,871
)
 
(31,370
)
Cash and cash equivalents at the beginning of the period
 
368,792

 
333,920

Cash and cash equivalents at the end of the period
 
$
205,921

 
$
302,550

 
 
 
 
 
Significant noncash investing activities:
 
 
 
 
Accrued holdback for acquisition
 
$

 
$
15,000

See accompanying notes to condensed consolidated financial statements.

6

Table of Contents
DIEBOLD, INCORPORATED AND SUBSIDIARIES
FORM 10-Q as of September 30, 2013
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
(dollars in thousands, except per share amounts)



NOTE 1: CONSOLIDATED FINANCIAL STATEMENTS
The accompanying unaudited condensed consolidated financial statements of Diebold, Incorporated and its subsidiaries (collectively, the Company) have been prepared in accordance with the instructions to Form 10-Q and therefore do not include all information and footnotes necessary for a fair presentation of financial position, results of operations and cash flows in conformity with U.S. generally accepted accounting principles (GAAP); however, such information reflects all adjustments (consisting solely of normal recurring adjustments) which are, in the opinion of management, necessary for a fair statement of the results for the interim periods.
The condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes contained in the Company’s annual report on Form 10-K for the year ended December 31, 2012. In addition, some of the Company’s statements in this quarterly report on Form 10-Q may involve risks and uncertainties that could significantly impact expected future results. The results of operations for the three and nine months ended September 30, 2013 are not necessarily indicative of results to be expected for the full year.
Error Correction and Reclassification The Company continues to work to remediate an internal control weakness pertaining to manufacturing and supply chain processes related to indirect tax incentives in one of its Brazilian subsidiaries. As part of remediation, during the second quarter of 2013, the Company identified an error related to prior year periods for Brazilian indirect tax incentives previously not appropriately recognized in product cost of goods sold. Prior-year amounts of product cost of sales, income tax expense, other current liabilities and retained earnings have been adjusted as management determined that the correction for each respective year is not material to each prior year period. This correction was recorded within the Company's operations in Brazil, included in the Diebold International (DI) reporting segment. As a result of applying the correction retrospectively, previously reported product cost of sales for the three and nine months ended September 30, 2012 increased by $1,633 and $4,899, respectively, and previously reported net income and diluted earnings per share decreased by $1,213 and $0.02 and $3,638 and $0.05, respectively. The aggregated amount of the correction reflected in other current liabilities and retained earnings as of December 31, 2012 was $18,489. There was no impact of the correction on previously reported cash flows from operations for the prior period.
The Company has also reclassified the presentation of certain prior-year information to conform to the current presentation.

Recently Adopted Accounting Guidance
In February 2013, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2013-02, Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income (ASU 2013-02), which required entities to disclose additional information for items reclassified out of accumulated other comprehensive income (AOCI). For items reclassified out of AOCI and into net income in their entirety, entities are required to disclose the effect of the reclassification on each affected net income line item. For AOCI reclassification items that are not reclassified in their entirety into net income, a cross-reference to other required U.S. GAAP disclosures is required. This information may be provided either in the notes or parenthetically on the face of the statement that reports net income as long as all the information is disclosed in a single location. However, an entity is prohibited from providing this information parenthetically on the face of the statement that reports net income if it has items that are not reclassified in their entirety into net income. The adoption of this update did not have a material impact on the Company's condensed consolidated financial statements; however, the Company provided additional disclosures as required by ASU 2013-02 in the condensed consolidated statements of comprehensive income (loss).

In March 2013, the FASB issued ASU 2013-05, Parent's Accounting for the Cumulative Translation Adjustment upon Derecognition of Certain Subsidiaries or Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity (ASU 2013-05). The objective of ASU 2013-05 is to resolve the diversity in practice regarding the release into net income of the cumulative translation adjustment upon derecognition of a subsidiary or group of assets within a foreign entity. The Company elected to early adopt ASU 2013-05 during the three months ended March 31, 2013, which did not have any impact on its condensed consolidated financial statements.

Recently Issued Accounting Guidance
In July 2013, the FASB issued 2013-11, Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists (ASU 2013-11), which requires entities to present an unrecognized tax benefit as a reduction of a deferred tax asset for a net operating loss (“NOL”) or tax credit carryforward whenever the NOL or tax

7

Table of Contents

credit carryforward would be available to reduce the additional taxable income or tax due if the tax position is disallowed. This accounting standard update requires entities to assess whether to net the unrecognized tax benefit with a deferred tax asset as of the reporting date. This guidance is effective for fiscal years beginning after December 15, 2013, with early adoption permitted. The Company will early adopt this guidance during the fourth quarter of 2013, and is not anticipating adoption of this update to have a material impact on the Company's consolidated financial statements.

NOTE 2: (LOSS) EARNINGS PER SHARE
Basic (loss) earnings per share is based on the weighted-average number of common shares outstanding. Diluted (loss) earnings per share includes the dilutive effect of potential common shares outstanding. Under the two-class method of computing (loss) earnings per share, non-vested share-based payment awards that contain rights to receive non-forfeitable dividends are considered participating securities. The Company’s participating securities include restricted stock units (RSUs), deferred shares and shares that were vested, but deferred by the employee. The Company calculated basic and diluted (loss) earnings per share under both the treasury stock method and the two-class method. For the three and nine months ended September 30, 2013 and 2012, there was no impact in the per share amounts calculated under the two methods. Accordingly, the treasury stock method is disclosed below.

The following represents amounts used in computing (loss) earnings per share and the effect on the weighted-average number of shares of dilutive potential common shares:
 
 
Three Months Ended
 
Nine Months Ended
 
 
September 30,
 
September 30,
 
 
2013
 
2012
 
2013
 
2012
Numerator:
 
 
 
 
 
 
 
 
(Loss) income used in basic and diluted earnings per share:
 
 
 
 
 
 
 
 
Net (loss) income attributable to Diebold, Incorporated
 
$
(21,690
)
 
$
16,221

 
$
(140,171
)
 
$
85,461

Denominator:
 
 
 
 
 
 
 
 
Weighted-average number of common shares used in basic earnings per share
 
63,825

 
63,211

 
63,648

 
63,003

Effect of dilutive shares (1)
 

 
923

 

 
927

Weighted-average number of shares used in diluted earnings per share
 
63,825

 
64,134

 
63,648

 
63,930

Net (loss) income attributable to Diebold, Incorporated:
 
 
 
 
 
 
 
 
Basic (loss) earnings per share
 
$
(0.34
)
 
$
0.26

 
$
(2.20
)
 
$
1.36

Diluted (loss) earnings per share
 
$
(0.34
)
 
$
0.25

 
$
(2.20
)
 
$
1.34

Anti-dilutive shares (in thousands):
 
 
 
 
 
 
 
 
Anti-dilutive shares not used in calculating diluted weighted-average shares
 
2,846

 
2,174

 
3,057

 
2,208

 
(1) Incremental shares of 479 thousand and 560 thousand were excluded from the computation of diluted (loss) earnings per share for the three and nine months ended September 30, 2013, respectively, because their effect is anti-dilutive due to the net loss attributable to Diebold, Incorporated.



















8

Table of Contents
DIEBOLD, INCORPORATED AND SUBSIDIARIES
FORM 10-Q as of September 30, 2013
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
(dollars in thousands, except per share amounts)


NOTE 3: EQUITY

The following table presents changes in shareholders' equity attributable to Diebold, Incorporated and the noncontrolling interests:
 
 
Three Months Ended
 
Nine Months Ended
 
 
September 30,
 
September 30,
 
 
2013
 
2012
 
2013
 
2012
Diebold, Incorporated shareholders' equity
 
 
 
 
 
 
 
 
Balance at beginning of period
 
$
620,122

 
$
834,674

 
$
791,474

 
$
813,348

Comprehensive income (loss) attributable to Diebold, Incorporated
 
52,732

 
23,177

 
(100,045
)
 
62,005

Common shares
 
172

 
45

 
895

 
983

Additional capital
 
3,850

 
4,758

 
23,439

 
25,527

Treasury shares
 
(1,692
)
 
(180
)
 
(3,660
)
 
(3,076
)
Dividends paid
 
(18,550
)
 
(18,260
)
 
(55,469
)
 
(54,573
)
Balance at end of period
 
$
656,634

 
$
844,214

 
$
656,634

 
$
844,214

 
 
 
 
 
 
 
 
 
Noncontrolling interests
 
 
 
 
 
 
 
 
Balance at beginning of period
 
$
32,965

 
$
32,024

 
$
35,348

 
$
31,274

Comprehensive income attributable to noncontrolling interests
 
1,507

 
944

 
2,588

 
2,806

Distributions/payable to noncontrolling interest holders
 
(13,448
)
 
(980
)
 
(16,912
)
 
(2,092
)
Balance at end of period
 
$
21,024

 
$
31,988

 
$
21,024

 
$
31,988


Reclassification adjustments recognized in AOCI for net gains on interest rate hedges and available-for-sale securities are included in interest expense and investment income, respectively, in the condensed consolidated statement of operations. Pension and other postretirement benefits AOCI components are included in the computation of net periodic benefit cost (refer to note 11 to the condensed consolidated financial statements).

NOTE 4: SHARE-BASED COMPENSATION
The Company’s share-based compensation payments to employees are recognized based on their grant-date fair values during the period in which the employee is required to provide services in exchange for the award. Share-based compensation is recognized as a component of selling and administrative expense. Total share-based compensation expense was $3,100 and $4,156 for the three months ended September 30, 2013 and 2012, respectively, and $14,070 and $9,860 for the nine months ended September 30, 2013 and 2012, respectively. Share-based compensation expense for the nine months ended September 30, 2013 included accelerated expense of $2,982 related to executive severance.

9

Table of Contents
DIEBOLD, INCORPORATED AND SUBSIDIARIES
FORM 10-Q as of September 30, 2013
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
(dollars in thousands, except per share amounts)


Options outstanding and exercisable as of September 30, 2013 under the Company’s 1991 Equity and Performance Incentive Plan (as Amended and Restated as of April 13, 2009) and changes during the nine months ended September 30, 2013, were as follows:
 
 
Number of
Shares
 
Weighted-
Average
Exercise
Price
 
Weighted-
Average
Remaining
Contractual
Term
 
Aggregate
Intrinsic
Value (1)
 
 
(in thousands)
 
(per share)
 
(in years)
 
 
Outstanding at January 1, 2013
 
2,668

 
$
37.56

 
 
 
 
Expired or forfeited
 
(318
)
 
36.97

 
 
 
 
Exercised
 
(386
)
 
26.56

 

 
 
Granted
 
338

 
30.46

 
 
 
 
Outstanding at September 30, 2013
 
2,302

 
$
38.44

 
5
 
$
716

Options exercisable at September 30, 2013
 
1,624

 
$
41.07

 
3
 
$
634

Options vested and expected to vest at September 30, 2013
 
2,272

 
$
38.53

 
5
 
$
713

(1)
The aggregate intrinsic value (the difference between the closing price of the Company’s common shares on the last trading day of the third quarter of 2013 and the exercise price, multiplied by the number of “in-the-money” options) that would have been received by the option holders had all option holders exercised their options on September 30, 2013. The amount of aggregate intrinsic value will change based on the fair market value of the Company’s common shares.
(2)
The options expected to vest are the result of applying the pre-vesting forfeiture rate assumption to total outstanding non-vested options.

The following table summarizes information on non-vested RSUs, performance shares and deferred shares for the nine months ended September 30, 2013:
 
 
Number of
Shares
 
Weighted-Average
Grant-Date Fair
Value
 
 
(in thousands)
 
 
RSUs:
 
 
 
 
Non-Vested at January 1, 2013
 
732

 
$
33.33

Forfeited
 
(107
)
 
33.72

Vested
 
(252
)
 
32.74

Granted
 
238

 
30.10

Non-Vested at September 30, 2013
 
611

 
$
32.27

Performance Shares (1):
 
 
 
 
Non-Vested at January 1, 2013
 
729

 
$
40.41

Forfeited
 
(328
)
 
38.00

Vested
 
(31
)
 
35.49

Granted
 
277

 
29.15

Non-Vested at September 30, 2013
 
647

 
$
37.04

Director Deferred Shares:
 
 
 
 
Non-Vested at January 1, 2013
 
20

 
$
40.54

Forfeited
 
(3
)
 
40.54

Vested
 
(17
)
 
40.54

Granted
 
31

 
29.73

Non-Vested at September 30, 2013
 
31

 
$
29.73

Vested at September 30, 2013
 
103

 
$
35.55

Outstanding at September 30, 2013
 
134

 
$
34.20

(1)
Non-vested performance shares are based on a maximum potential payout. Actual shares granted at the end of the performance period may be less than the maximum potential payout level depending on achievement of performance share objectives.


10

Table of Contents
DIEBOLD, INCORPORATED AND SUBSIDIARIES
FORM 10-Q as of September 30, 2013
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
(dollars in thousands, except per share amounts)


NOTE 5: INCOME TAXES

The effective tax rate on the loss for the three months ended September 30, 2013 was 28.2 percent. The effective rate on the the income for the three months ended September 30, 2012 was 30.5 percent. The decrease was mainly due to the reduced tax benefit attributable to the non-deductible portion of the Company's Brazil goodwill impairment, partially offset by additional non-recurring discrete tax items recorded in the quarter.

The effective tax rate on the loss before taxes was (95.3) percent for the nine months ended September 30, 2013. The negative tax rate for 2013 is a result of tax expense of approximately $47,000 related to the repatriation of previously undistributed earnings and the establishment of a valuation allowance of approximately $39,200 on deferred tax assets in the Company's Brazilian manufacturing facility, both in the second quarter of 2013. The tax impact of the goodwill impairment recorded in the third quarter of 2013 offset a portion of the previous quarter discrete tax expense, reducing the negative effective tax rate. The effective tax rate on income was 28.0 percent for the nine months ended September 30, 2012.

NOTE 6: INVESTMENTS
The Company’s investments, primarily in Brazil, consist of certificates of deposit and U.S. dollar indexed bond funds, which are classified as available-for-sale and stated at fair value based upon quoted market prices and net asset values, respectively. Unrealized gains and losses are recorded in AOCI. Realized gains and losses are recognized in investment income and are determined using the specific identification method. Realized gains, net from the sale of securities were $1,533 and $1,728 for the three months ended September 30, 2013 and 2012, respectively, and $1,725 and $3,236 for the nine months ended September 30, 2013 and 2012, respectively. Proceeds from the sale of available-for-sale securities were $22,711 and $33,437 during the nine months ended September 30, 2013 and 2012, respectively.

The Company’s investments, excluding cash surrender value of insurance contracts of $69,729 and $70,318 as of September 30, 2013 and December 31, 2012, respectively, consist of the following:
 
 
Cost Basis
 
Unrealized Gain
 
Fair Value
As of September 30, 2013
 
 
 
 
 
 
Short-term investments:
 
 
 
 
 
 
Certificates of deposit
 
$
160,286

 
$

 
$
160,286

U.S. dollar indexed bond funds
 
37,498

 
1,919

 
39,417

 
 
$
197,784

 
$
1,919

....
$
199,703

Long-term investments:
 
 
 
 
 
 
Assets held in a rabbi trust
 
$
5,867

 
$
1,269

 
$
7,136

 
 
 
 
 
 
 
As of December 31, 2012
 
 
 
 
 
 
Short-term investments:
 
 
 
 
 
 
Certificates of deposit
 
$
258,518

 
$

 
$
258,518

U.S. dollar indexed bond funds
 
3,249

 
119

 
3,368

 
 
$
261,767

 
$
119

 
$
261,886

Long-term investments:
 
 
 
 
 
 
Assets held in a rabbi trust
 
$
6,266

 
$
517

 
$
6,783


NOTE 7: ALLOWANCE FOR CREDIT LOSSES
Trade Receivables The Company evaluates the collectability of trade receivables based on (1) a percentage of sales related to historical loss experience and current trends and (2) periodic adjustments for known events such as specific customer circumstances and changes in the aging of accounts receivable balances. After all efforts at collection have been unsuccessful, the account is deemed uncollectible and is written off.


11

Table of Contents
DIEBOLD, INCORPORATED AND SUBSIDIARIES
FORM 10-Q as of September 30, 2013
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
(dollars in thousands, except per share amounts)


Financing Receivables The Company evaluates the collectability of notes and finance lease receivables (collectively, financing receivables) on a customer-by-customer basis and evaluates specific customer circumstances, aging of invoices, credit risk changes and payment patterns and historical loss experience. When the collectability is determined to be at risk based on the above criteria, the Company records the allowance for credit losses, which represents the Company’s current exposure less estimated reimbursement from insurance claims. After all efforts at collection have been unsuccessful, the account is deemed uncollectible and is written off. The following table summarizes the Company’s allowance for credit losses for the nine months ended September 30, 2013 and 2012:

 
 
Finance
Leases
 
Notes
Receivable
 
Total
Allowance for credit losses
 
 
 
 
 
 
Balance at January 1, 2013
 
$
525

 
$
2,047

 
$
2,572

Provision for credit losses
 
8

 

 
8

Recoveries
 
3

 

 
3

Write-offs
 
(90
)
 
(2,047
)
 
(2,137
)
Balance at September 30, 2013
 
$
446

 
$

 
$
446

 
 
 
 
 
 
 
Balance at January 1, 2012

$
210


$
2,047


$
2,257

Provision for credit losses

261




261

Recoveries

48




48

Write-offs






Balance at September 30, 2012

$
519


$
2,047


$
2,566


The Company's allowance of $446 and $2,566 at September 30, 2013 and 2012, respectively, all resulted from individual impairment evaluation. As of September 30, 2013, balances of finance leases and notes receivable were $88,216 and $16,343, respectively. As of September 30, 2012, balances of finance leases and notes receivable were $100,436 and $12,882, respectively.
The Company records interest income and any fees or costs related to financing receivables using the effective interest method over the term of the lease or loan. The Company reviews the aging of its financing receivables to determine past due and delinquent accounts. Credit quality is reviewed at inception and is re-evaluated as needed based on customer-specific circumstances. Receivable balances 60 days to 89 days past due are reviewed and may be placed on nonaccrual status based on customer-specific circumstances. Receivable balances are placed on nonaccrual status upon reaching greater than 89 days past due. Upon receipt of payment on nonaccrual financing receivables, interest income is recognized and accrual of interest is resumed once the account has been made current or the specific circumstances have been resolved.
As of September 30, 2013 and December 31, 2012, the recorded investment in past-due financing receivables on nonaccrual status was $2,489 and $2,060, respectively, and there were no recorded investments in finance receivables past due 90 days or more and still accruing interest. The recorded investment in impaired notes receivable was $0 as of September 30, 2013 and was $2,047 as of December 31, 2012 ,which was fully reserved. The following table summarizes the Company’s aging of past-due notes receivable balances:
 
 
September 30, 2013
 
December 31, 2012
30-59 days past due
 
$

 
$

60-89 days past due
 

 

> 89 days past due
 

 
1,840

Total past due
 
$

 
$
1,840



12

Table of Contents
DIEBOLD, INCORPORATED AND SUBSIDIARIES
FORM 10-Q as of September 30, 2013
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
(dollars in thousands, except per share amounts)


NOTE 8: INVENTORIES
Major classes of inventories are summarized as follows:
 
 
September 30, 2013
 
December 31, 2012
Finished goods
 
$
228,931

 
$
183,286

Service parts
 
144,157

 
151,189

Raw materials and work in process
 
107,332

 
78,521

Total inventories
 
$
480,420

 
$
412,996

 
NOTE 9: GOODWILL AND OTHER ASSETS
Goodwill In 2012, goodwill was reviewed for impairment based on a two-step test, which resulted in no impairment in any of the Company's reporting units. Due to deteriorating macro-economic outlook, structural changes to an auction-based purchasing environment and new competitors entering the market over the past several quarters, management reduced its earnings outlook for the Brazil business unit during the third quarter of 2013. As a result, the Company performed an other-than-annual assessment for its Brazil reporting unit based on a two-step impairment test and concluded that the goodwill within the Brazil reporting unit was partially impaired. The Company recorded a $70,000 pre-tax, non-cash goodwill impairment charge during the third quarter of 2013.
The two-step impairment test was used to measure the amount of impairment loss to be recognized. In the first step, the Company compares the fair value of each reporting unit with its carrying value. The fair value is determined based upon discounted estimated future cash flows as well as the market approach or guideline public company method. The Company’s Step 1 impairment test of goodwill of a reporting unit is based upon the fair value of the reporting unit, defined as the price that would be received to sell the net assets or transfer the net liabilities in an orderly transaction between market participants at the assessment date. In the event that the net carrying amount exceeds the fair value, a Step 2 test must be performed whereby the fair value of the reporting unit’s goodwill must be estimated to determine if it is less than its net carrying amount. In its two-step test, the Company uses the discounted cash flow method and the guideline company method for determining the fair value of its reporting units. Under these methods, the determination of implied fair value of the goodwill for a particular reporting unit is the excess of the fair value of a reporting unit over the amounts assigned to its assets and liabilities in the same manner as the allocation in a business combination.
The techniques used in the Company's qualitative assessment and, if necessary, two-step impairment test have incorporated a number of assumptions that the Company believes to be reasonable and to reflect market conditions forecast at the assessment date. Assumptions in estimating future cash flows are subject to a high degree of judgment. The Company makes all efforts to forecast future cash flows as accurately as possible with the information available at the time a forecast is made. To this end, the Company evaluates the appropriateness of its assumptions as well as its overall forecasts by comparing projected results of upcoming years with actual results of preceding years and validating that differences therein are reasonable. Key assumptions, all of which are Level 3 inputs (refer to note 16), relate to price trends, material costs, discount rate, customer demand, and the long-term growth and foreign exchange rates. A number of benchmarks from independent industry and other economic publications were also used. Changes in assumptions and estimates after the assessment date may lead to an outcome where impairment charges would be required in future periods. Specifically, actual results may vary from the Company’s forecasts and such variations may be material and unfavorable, thereby triggering the need for future impairment tests where the conclusions may differ in reflection of prevailing market conditions.
Other Assets Included in other assets are net capitalized software development costs of $41,674 and $49,513 as of September 30, 2013 and December 31, 2012, respectively. Amortization expense on capitalized software of $5,369 and $3,985 was included in product cost of sales for the three months ended September 30, 2013 and 2012, respectively, and $16,620 and $12,586 was included in product cost of sales for the nine months ended September 30, 2013 and 2012, respectively. Other long-term assets also consist of patents, trademarks, other intangible assets, and financing receivables. Where applicable, other assets are stated at cost and, if applicable, are amortized ratably over the relevant contract period or the estimated life of the assets. Fees to renew or extend the term of the Company’s intangible assets are expensed when incurred.
In August 2012, the Company acquired GAS Tecnologia (GAS), a Brazilian Internet banking, online payment and mobile banking security company. At June 30, 2013, the Company finalized the purchase accounting with respect to opening balance sheet valuations. Amortizable intangible assets resulting from the acquisition was $16,000.

13

Table of Contents
DIEBOLD, INCORPORATED AND SUBSIDIARIES
FORM 10-Q as of September 30, 2013
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
(dollars in thousands, except per share amounts)


Impairment of long-lived assets is recognized when events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. If the expected future undiscounted cash flows are less than the carrying amount of the asset group, an impairment loss may be recognized at that time to reduce the asset to the lower of its fair value or its net book value.

NOTE 10: DEBT
Outstanding debt balances were as follows:
 
 
September 30, 2013
 
December 31, 2012
Notes payable:
 
 
 
 
Uncommitted lines of credit
 
$
26,103

 
$
33,916

Other
 
670

 
296

 
 
$
26,773

 
$
34,212

Long-term debt:
 
 
 
 
Credit facility
 
$
320,007

 
$
300,000

Senior notes
 
225,000

 
300,000

Industrial development revenue bonds
 
11,900

 
11,900

Other
 
4,688

 
5,634

 
 
$
561,595

 
$
617,534

As of September 30, 2013, the Company had various international short-term uncommitted lines of credit with borrowing limits of $108,322. The weighted-average interest rate on outstanding borrowings on the short-term uncommitted lines of credit as of September 30, 2013 and December 31, 2012 was 3.96 percent and 2.81 percent, respectively. The increase in the weighted-average interest rate is attributable to the change in mix of borrowings in foreign entities. Short-term uncommitted lines mature in less than one year. The amount available under the short-term uncommitted lines at September 30, 2013 was $82,219.
As of September 30, 2013, the Company had borrowing limits under its five-year credit facility totaling $500,000, which expires in June 2016. Under the terms of the credit facility agreement, the Company has the ability, subject to various approvals, to increase the borrowing limits by $250,000. Up to $50,000 of the revolving credit facility is available under a swing line sub-facility. The weighted-average interest rate on outstanding credit facility borrowings as of September 30, 2013 and December 31, 2012 was 1.34 percent and 1.33 percent, respectively, which is variable based on the London Interbank Offered Rate (LIBOR). The amount available under the credit facility as of September 30, 2013 was $179,993.

In March 2006, the Company issued senior notes in an aggregate principal amount of $300,000 with a weighted-average fixed interest rate of 5.50 percent. Additionally, the Company entered into a derivative transaction to hedge interest rate risk on $200,000 of the senior notes, which was treated as a cash flow hedge. This reduced the effective interest rate from 5.50 percent to 5.36 percent. The Company funded the repayment of $75,000 of the senior notes at maturity in March 2013 using its revolving credit facility. The maturity dates of the remaining senior notes are staggered, with $175,000 and $50,000 due in 2016 and 2018, respectively.
In 1997, industrial development revenue bonds were issued on behalf of the Company. The proceeds from the bond issuances were used to construct new manufacturing facilities in the United States. The Company guaranteed the payments of principal and interest on the bonds by obtaining letters of credit. The bonds were issued with a 20-year original term and are scheduled to mature in 2017. Each industrial development revenue bond carries a variable interest rate, which is reset weekly by the remarketing agents. The weighted-average interest rate on the bonds was 0.37 percent and 0.49 percent as of September 30, 2013 and December 31, 2012, respectively.
The Company’s debt agreements contain various restrictive financial covenants, including net debt to capitalization and net interest coverage ratios. As of September 30, 2013, the Company was in compliance with the financial and other covenants in its debt agreements.






14

Table of Contents
DIEBOLD, INCORPORATED AND SUBSIDIARIES
FORM 10-Q as of September 30, 2013
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
(dollars in thousands, except per share amounts)


NOTE 11: BENEFIT PLANS
Qualified Pension Benefits The Company has pension plans covering certain U.S. employees that have been closed to new participants since July 1, 2003. Plans that cover certain salaried employees provide pension benefits based on the employee’s compensation during the ten years before retirement. The Company’s funding policy for salaried plans is to contribute annually based on actuarial projections and applicable regulations. Plans covering certain hourly employees and union members generally provide benefits of stated amounts for each year of service. The Company’s funding policy for hourly plans is to make at least the minimum annual contributions required by applicable regulations. Employees of the Company’s operations in countries outside of the U.S. participate to varying degrees in local pension plans, which in the aggregate are not significant.
Supplemental Executive Retirement Benefits The Company has non-qualified pension plans to provide supplemental executive retirement plan (SERP) benefits to certain officers. Benefits are payable at retirement based upon a percentage of the participant's compensation, as defined.
Plan Freeze and Re-measurement In July 2013, the Company's board of directors approved freezing certain pension and SERP plan benefits effective as of December 31, 2013 for U.S.-based salaried employees. The Company recognized the plan freeze in the three months ended September 30, 2013 as a curtailment, since it eliminates for a significant number of participants the accrual of defined benefits for all of their future services. The impact of the curtailment includes the one-time accelerated recognition of outstanding unamortized pre-tax prior service cost of $809 within general and administrative expense and a pre-tax reduction in AOCI of $52,462, attributable to the decrease in long-term pension liabilities. This curtailment event triggered a re-measurement for the affected benefit plans as of July 31, 2013 using a discount rate of 5.06 percent. The re-measurement resulted in a further reduction of long-term pension liabilities and AOCI (pre-tax) related to the actuarial gain occurring during the year of approximately $71,000. Freezing certain pension and SERP plan benefits, coupled with an anticipated increase in discount rate, is expected to result in a significant reduction of future pension expense.
Other Benefits In addition to providing pension benefits, the Company provides healthcare and life insurance benefits (referred to as other benefits) for certain retired employees. Eligible employees may be entitled to these benefits based upon years of service with the Company, age at retirement and collective bargaining agreements. Currently, the Company has made no commitments to increase these benefits for existing retirees or for employees who may become eligible for these benefits in the future. There are no plan assets and the Company funds the benefits as the claims are paid.
The following table sets forth the net periodic benefit cost for the Company’s defined benefit pension plans and other benefits for the three months ended September 30:
 
 
Pension Benefits
 
Other Benefits
 
 
2013
 
2012
 
2013
 
2012
Components of net periodic benefit cost
 
 
 
 
 
 
 
 
Service cost
 
$
2,647

 
$
2,862

 
$

 
$

Interest cost
 
6,865

 
7,957

 
157

 
204

Expected return on plan assets
 
(9,017
)
 
(10,205
)
 

 

Amortization of prior service (benefit) cost
 
(136
)
 
65

 
(122
)
 
(130
)
Recognized net actuarial loss
 
2,529

 
4,207

 
105

 
123

Curtailment loss
 
809



 



Net periodic pension benefit cost
 
$
3,697

 
$
4,886

 
$
140

 
$
197







15

Table of Contents
DIEBOLD, INCORPORATED AND SUBSIDIARIES
FORM 10-Q as of September 30, 2013
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
(dollars in thousands, except per share amounts)


The following table sets forth the net periodic benefit cost for the Company’s defined benefit pension plans and other benefits for the nine months ended September 30:
 
 
Pension Benefits
 
Other Benefits
 
 
2013
 
2012
 
2013
 
2012
Components of net periodic benefit cost
 
 
 
 
 
 
 
 
Service cost
 
$
9,308

 
$
8,585

 
$

 
$

Interest cost
 
20,778

 
23,873

 
471

 
611

Expected return on plan assets
 
(26,622
)
 
(30,616
)
 

 

Amortization of prior service (benefit) cost
 
(99
)
 
194

 
(366
)
 
(388
)
Recognized net actuarial loss
 
13,385

 
12,601

 
317

 
366

Curtailment loss (1)
 
1,968

 

 

 

Net periodic pension benefit cost
 
$
18,718

 
$
14,637

 
$
422

 
$
589

(1) The curtailment recognized during the nine months ended September 30, 2013 resulted from the departure of certain executive officers and the U.S. salary plan benefit freeze and was recorded within selling and administrative expense.
Contributions
There have been changes to the expected 2013 plan year contribution amounts previously disclosed. The benefit freeze of the defined-benefit pension plan for U.S.-based employees, coupled with higher discount rates, improved the funded status of the salaried plan and, therefore, the Company has no plans to make contributions to the pension plan for the next twelve months. For the nine months ended September 30, 2013 and 2012, contributions of $2,662 and $14,915, respectively, were made to the qualified and non-qualified pension plans.

NOTE 12: GUARANTEES AND PRODUCT WARRANTIES
In 1997, industrial development revenue bonds were issued on behalf of the Company. The Company guaranteed the payments of principal and interest on the bonds (refer to note 10) by obtaining letters of credit. The carrying value of the bonds was $11,900 as of September 30, 2013 and December 31, 2012.
The Company provides its global operations guarantees and standby letters of credit through various financial institutions to suppliers, customers, regulatory agencies and insurance providers. If the Company is not able to make payment or fulfill contractual obligations, the suppliers, customers, regulatory agencies and insurance providers may draw on the pertinent bank. At September 30, 2013, the maximum future payment obligations related to these various guarantees totaled $86,883, of which $26,035 represented standby letters of credit to insurance providers, and no associated liability was recorded. At December 31, 2012, the maximum future payment obligations relative to these various guarantees totaled $80,662, of which $23,435 represented standby letters of credit to insurance providers, and no associated liability was recorded.
The Company provides its customers a manufacturer’s warranty and records, at the time of the sale, a corresponding estimated liability for potential warranty costs. Estimated future obligations due to warranty claims are based upon historical factors such as labor rates, average repair time, travel time, number of service calls per machine and cost of replacement parts.
Changes in the Company’s warranty liability balance are illustrated in the following table:
 
 
2013
 
2012
Balance at January 1
 
$
81,751

 
$
63,355

Current period accruals (a)
 
34,300

 
45,472

Current period settlements
 
(40,564
)
 
(39,917
)
Balance at September 30
 
$
75,487

 
$
68,910

(a)
includes the impact of foreign exchange rate fluctuations







16

Table of Contents
DIEBOLD, INCORPORATED AND SUBSIDIARIES
FORM 10-Q as of September 30, 2013
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
(dollars in thousands, except per share amounts)


NOTE 13: COMMITMENTS AND CONTINGENCIES

Contractual Obligations
At September 30, 2013, the Company had purchase commitments due within one year of $15,420 for materials through contract manufacturing agreements at negotiated prices.

Indirect Tax Contingencies
The Company accrues non income-tax liabilities for indirect tax matters when management believes that a loss is probable and the amounts can be reasonably estimated, while contingent gains are recognized only when realized. In the event any losses are sustained in excess of accruals, they are charged against income. In evaluating indirect tax matters, management takes into consideration factors such as historical experience with matters of similar nature, specific facts and circumstances, and the likelihood of prevailing. Management evaluates and updates accruals as matters progress over time. It is reasonably possible that some of the matters for which accruals have not been established could be decided unfavorably to the Company and could require recognizing future expenditures. Also, statutes of limitations could expire without the Company paying the taxes for matters for which accruals have been established which could result in the recognition of future gains upon reversal of these accruals at that time.
At September 30, 2013, the Company was a party to several indirect tax claims from various taxing authorities globally that were incurred in the normal course of business, none of which individually or in the aggregate is considered material by management in relation to the Company’s financial position or results of operations. In management’s opinion, the condensed consolidated financial statements would not be materially affected by the outcome of these indirect tax claims and/or proceedings or asserted claims. In addition to these routine indirect tax matters, the Company was a party to the proceeding described below:
In August 2012, one of the Company's Brazilian subsidiaries was notified of a tax assessment of approximately $133,000, including penalties and interest, regarding certain Brazilian federal indirect taxes (Industrialized Products Tax, Import Tax, Programa de Integração Social and Contribution to Social Security Financing) for 2008 and 2009. The assessment alleges improper importation of certain components into Brazil's free trade zone that would nullify certain indirect tax incentives. On September 10, 2012, the Company filed its administrative defenses with the tax authorities. This proceeding is currently pending an administrative level decision, which could negatively impact Brazilian federal indirect taxes in other years that remain open under statute. It is reasonably possible that the Company could be required to pay taxes, penalties and interest related to this matter, which could be material to the Company's consolidated financial statements. Additionally, in May 2013, the U.S. Securities and Exchange Commission (SEC) requested that the Company retain certain documents and produce certain records relating to the assessment, and the Company is complying with that request.

At September 30, 2013 and December 31, 2012, the Company had an accrual of approximately $26,000 for certain indirect tax positions in both periods. A loss contingency is reasonably possible if it has a more than remote but less than probable chance of occurring. Although management believes the Company has valid defenses with respect to its indirect tax positions, it is reasonably possible that a loss could occur in excess of the estimated accrual, for which the Company estimated the aggregate risk at September 30, 2013 to be up to approximately $381,000 for its material indirect tax matters.

Legal Contingencies
At September 30, 2013, the Company was a party to several lawsuits that were incurred in the normal course of business, none of which individually or in the aggregate is considered material by management in relation to the Company’s financial position or results of operations. In addition, the Company has indemnification obligations with certain former employees and costs associated with these indemnifications are expensed as incurred. In management’s opinion, the condensed consolidated financial statements would not be materially affected by the outcome of these legal proceedings, commitments or asserted claims. In addition to these routine legal proceedings, the Company was a party to the legal proceedings described below:

Securities Action
On June 30, 2010, a shareholder filed a putative class action complaint in the United States District Court for the Northern District of Ohio alleging violations of the federal securities laws against the Company, certain current and former officers, and the Company's independent auditors (Louisiana Municipal Police Employees Retirement System v. KPMG et al., No. 10-CV-1461). The complaint seeks unspecified compensatory damages on behalf of a class of persons who purchased the Company's stock between June 30, 2005 and January 15, 2008 and fees and expenses related to the lawsuit. The complaint generally relates to the matters set forth

17

Table of Contents
DIEBOLD, INCORPORATED AND SUBSIDIARIES
FORM 10-Q as of September 30, 2013
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
(dollars in thousands, except per share amounts)


in the court documents filed by the SEC in June 2010 finalizing the settlement of civil charges stemming from the investigation of the Company conducted by the Division of Enforcement of the SEC. In the second quarter 2013, the Company recorded a $30,000 pre-tax charge within selling and administrative expense related to an agreement in principle to settle this matter, which is included in other current liabilities. Additionally, the Company recorded an offsetting $12,755 pre-tax credit within selling and administrative expense related to the Company's estimate of anticipated insurance recovery, which is included in other current assets.

Global Foreign Corrupt Practices Act (FCPA) Review
During the second quarter of 2010, while conducting due diligence in connection with a potential acquisition in Russia, the Company identified certain transactions and payments by its subsidiary in Russia (primarily during 2005 to 2008) that potentially implicate the FCPA, particularly the books and records provisions of the FCPA. As a result, the Company conducted a global internal review and collected information related to its global FCPA compliance. In the fourth quarter of 2010, the Company identified certain transactions within its Asia Pacific operation that occurred over the past several years that may also potentially implicate the FCPA. The Company continues to monitor its ongoing global compliance with the FCPA.

The Company voluntarily self-reported its findings to the SEC and the U.S. Department of Justice (DOJ) and cooperated with these agencies in their review. The Company was previously informed that the SEC's inquiry had been converted to a formal, non-public investigation. The Company also received a subpoena for documents from the SEC and a voluntary request for documents from the DOJ in connection with the investigation.

The Company has reached agreement with the DOJ and the SEC to the terms of a settlement of their inquiries, which terms were filed in federal court on October 22, 2013. These terms include combined payments to the U.S. government of $48,000 in disgorgement, penalties, and pre-judgment interest and the appointment of an independent compliance monitor for a minimum period of 18 months. As a result, in the second quarter of 2013, the Company recorded a $28,000 pre-tax charge within selling and administrative expense for additional estimated losses related to this matter. As of September 30, 2013 and December 31, 2012, the total accrual for estimated losses was $48,000 and $20,000, respectively. The Company remitted the combined payments to the U.S. government in November 2013.

NOTE 14: DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES
The Company uses derivatives to mitigate the economic consequences associated with fluctuations in currencies and interest rates.
FOREIGN EXCHANGE
Net Investment Hedges The Company has international subsidiaries with net balance sheet positions that generate cumulative translation adjustments within AOCI. The Company uses derivatives to manage potential changes in value of its net investments in Brazil. The Company uses the forward-to-forward method for its quarterly retrospective and prospective assessments of hedge effectiveness. No ineffectiveness results if the notional amount of the derivative matches the portion of the net investment designated as being hedged because the Company uses derivative instruments with underlying exchange rates consistent with its functional currency and the functional currency of the hedged net investment. Changes in value that are deemed effective are accumulated in AOCI where they will remain until they are reclassified to income together with the gain or loss on the entire investment upon substantial liquidation of the subsidiary. The fair value of the Company’s net investment hedge contracts was $(1,136) and $0 as of September 30, 2013 and December 31, 2012, respectively. The net (loss) gain recognized in AOCI on net investment hedge derivative instruments was $(3,764) and $(463) in the three months ended September 30, 2013 and 2012, respectively, and $223 and $1,805 in the nine months ended September 30, 2013 and 2012, respectively.
Non-Designated Hedges A substantial portion of the Company’s operations and revenues are international. As a result, changes in foreign exchange rates can create substantial foreign exchange gains and losses from the revaluation of non-functional currency monetary assets and liabilities. The Company’s policy allows the use of foreign exchange forward contracts with maturities of up to 24 months to mitigate the impact of currency fluctuations on those foreign currency asset and liability balances. The Company elected not to apply hedge accounting to its foreign exchange forward contracts. Thus, spot-based gains/losses offset revaluation gains/losses within foreign exchange loss, net and forward-based gains/losses represent interest expense. The fair value of the Company’s non-designated foreign exchange forward contracts was $(256) and $47 as of September 30, 2013 and December 31, 2012, respectively.

18

Table of Contents
DIEBOLD, INCORPORATED AND SUBSIDIARIES
FORM 10-Q as of September 30, 2013
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
(dollars in thousands, except per share amounts)


The following table summarizes the (loss) gain recognized on non-designated foreign-exchange derivative instruments:
 
 
Three Months Ended
 
Nine Months Ended
 
 
September 30,
 
September 30,

 
2013
 
2012
 
2013
 
2012
Interest expense
 
$
(2,099
)
 
$
(1,121
)
 
$
(4,726
)
 
$
(3,787
)
Foreign exchange (loss) gain, net
 
(680
)
 
(3,108
)
 
10,275

 
(2,509
)
 
 
$
(2,779
)
 
$
(4,229
)
 
$
5,549

 
$
(6,296
)
INTEREST RATE
Cash Flow Hedges The Company has variable rate debt and is subject to fluctuations in interest related cash flows due to changes in market interest rates. The Company’s policy allows derivative instruments designated as cash flow hedges that fix a portion of future variable-rate interest expense. As of September 30, 2013, the Company had two pay-fixed receive-variable interest rate swaps, with a total notional amount of $50,000, to hedge against changes in the LIBOR benchmark interest rate on a portion of the Company’s LIBOR-based borrowings. Changes in value that are deemed effective are accumulated in AOCI and reclassified to interest expense when the hedged interest is accrued. To the extent that it becomes probable that the Company’s variable rate borrowings will not occur, the gains or losses on the related cash flow hedges will be reclassified from AOCI to interest expense. The fair value of the Company’s interest rate contracts was $(2,604) and $(3,558) as of September 30, 2013 and December 31, 2012, respectively.
In December 2005 and January 2006, the Company executed cash flow hedges by entering into receive-variable and pay-fixed interest rate swaps, with a total notional amount of $200,000, related to the senior notes issuance in March 2006. Amounts previously recorded in AOCI related to the pre-issuance cash flow hedges will continue to be reclassified on a straight-line basis through February 2016.

The gain or loss on designated cash flow hedge derivative instruments for the three and nine months ended September 30, 2013 and 2012 were not material. Gains and losses related to interest rate contracts that are reclassified from AOCI are recorded in interest expense on the statements of operations. The Company anticipates reclassifying $942 from AOCI to interest expense within the next 12 months.

NOTE 15: RESTRUCTURING, IMPAIRMENT AND OTHER CHARGES
Restructuring Charges
The following table summarizes the impact of the Company’s restructuring charges (accrual adjustments) on the condensed consolidated statements of operations:
 
 
Three Months Ended
 
Nine Months Ended
 
 
September 30,
 
September 30,
 
 
2013
 
2012
 
2013
 
2012
Cost of sales – services
 
$
2,124

 
$
956

 
$
8,983

 
$
91

Cost of sales – products
 
212

 
(2,064
)
 
429

 
(1,959
)
Selling and administrative expense
 
1,859

 
2,454

 
9,375

 
5,654

Research, development and engineering expense
 
151

 
1,116

 
2,617

 
1,116

Total
 
$
4,346

 
$
2,462

 
$
21,404

 
$
4,902



19

Table of Contents
DIEBOLD, INCORPORATED AND SUBSIDIARIES
FORM 10-Q as of September 30, 2013
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
(dollars in thousands, except per share amounts)


The following table summarizes the Company’s net restructuring charges for its Diebold North America (DNA) and DI reporting segments:
 
 
Three Months Ended
 
Nine Months Ended
 
 
September 30,
 
September 30,
 
 
2013
 
2012
 
2013
 
2012
DNA
 
 
 
 
 
 
 
 
Severance
 
$
962

 
$
3,313

 
$
14,373

 
$
4,870

Other
 
224

 

 
224

 

DI
 
 
 
 
 
 
 
 
Severance
 
2,827

 
(621
)
 
6,334

 
(329
)
Other
 
333

 
(230
)
 
473

 
361

Total
 
$
4,346

 
$
2,462

 
$
21,404

 
$
4,902


During the first quarter of 2013, the Company announced a multi-year realignment plan. Certain aspects of this plan were previously disclosed under the Company's global realignment plan and global shared services plan. This multi-year realignment will focus on globalizing the Company's service organization, creating a unified center-led global organization for research and development as well as transform the Company's general and administrative cost structure. All restructuring charges for the three and nine months ended September 30, 2013 and 2012 related to the Company's multi-year realignment plan. As of September 30, 2013, the Company anticipates additional restructuring costs of $94,000 to $121,000 to be incurred through the end of 2014, inclusive of $48,000 to $59,000 of non-cash voluntary early retirement program restructuring charges to be incurred in the fourth quarter 2013. As management finalizes certain aspects of the realignment plan, the anticipated future costs related to this plan are subject to change. As of September 30, 2013, cumulative total restructuring costs for the multi-year realignment plan were $26,179 and $13,955 in DNA and DI, respectively.

The following table summarizes the Company’s restructuring accrual balances:
 
 
2013
 
2012
Balance at January 1
 
$
11,844

 
$
10,136

Liabilities incurred
 
21,404

 
4,902

Liabilities paid
 
(27,239
)
 
(5,347
)
Balance at September 30
 
$
6,009

 
$
9,691


Impairment and Other Charges
During the third quarter of 2013, the Company recorded a $70,000 pre-tax, non-cash goodwill impairment charge related to its Brazil reporting unit (refer to note 9) within DI.
During the third quarter of 2012, the Company determined an investment related to its 50 percent ownership in Shanghai Diebold King Safe Company, Ltd. was partially impaired and recorded an impairment charge of $7,930, which was allocated to the DNA and DI segments. During the second quarter of 2012, the Company recorded an impairment charge within DNA of $6,701 related to a portion of its global enterprise resource planning (ERP) system. Previously capitalized software and software-related costs were impaired due to changes in the ERP implementation plan related to configuration and design.
Other charges consist of items that the Company determines are non-routine in nature. Net non-routine expenses of $56,364 and $1,913 impacted the nine months ended September 30, 2013 and 2012, respectively. Non-routine expenses within selling and administrative expense for the first nine months of 2013 included $28,000 of estimated pre-tax losses related to the potential outcome of the FCPA investigation in addition to related legal fees, a $17,245 pre-tax net charge related to settlement of the securities legal action (refer to note 13), and executive severance costs, including accelerated share-based compensation expense of $2,982 (pre-tax). Non-routine income for 2013 related to a pre-tax gain of $2,191 from the sale of certain U.S. manufacturing operations to a long-time supplier. Net non-routine expenses for 2012 consisted primarily of legal and compliance costs related to the FCPA investigation.



20

Table of Contents
DIEBOLD, INCORPORATED AND SUBSIDIARIES
FORM 10-Q as of September 30, 2013
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
(dollars in thousands, except per share amounts)


NOTE 16: FAIR VALUE OF ASSETS AND LIABILITIES
The Company measures its financial assets and liabilities using one or more of the following three valuation techniques:
Market approach – Prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities.
Cost approach – Amount that would be required to replace the service capacity of an asset (replacement cost).
Income approach – Techniques to convert future amounts to a single present amount based upon market expectations.
The hierarchy that prioritizes the inputs to valuation techniques used to measure fair value is divided into three levels:
Level 1 – Unadjusted quoted prices in active markets for identical assets or liabilities.
Level 2 – Unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active or inputs, other than quoted prices in active markets, that are observable either directly or indirectly.
Level 3 – Unobservable inputs for which there is little or no market data.
 
A financial asset or liability’s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement in its entirety.

Assets and Liabilities Recorded at Fair Value
Assets and liabilities subject to fair value measurement are as follows:
 
 
September 30, 2013
 
December 31, 2012
 
 
 
 
Fair Value Measurements Using
 
 
 
Fair Value Measurements Using
 
 
Fair Value
 
Level 1
 
Level 2
 
Fair Value
 
Level 1
 
Level 2
Assets
 
 
 
 
 
 
 
 
 
 
 
 
Short-term investments:
 
 
 
 
 
 
 
 
 
 
 
 
Certificates of deposit
 
$
160,286

 
$
160,286

 
$

 
$
258,518

 
$
258,518

 
$

U.S. dollar indexed bond funds
 
39,417

 

 
39,417

 
3,368

 

 
3,368

Assets held in a rabbi trust
 
7,136

 
7,136

 

 
6,783

 
6,783

 

Foreign exchange forward contracts
 
469

 

 
469

 
960

 

 
960

Total
 
$
207,308

 
$
167,422

 
$
39,886

 
$
269,629

 
$
265,301


$
4,328

Liabilities
 

 
 
 
 
 
 
 
 
 
 
Deferred compensation
 
$
7,136

 
$
7,136

 
$

 
$
6,783

 
$
6,783

 
$

Foreign exchange forward contracts
 
1,861

 

 
1,861

 
913

 

 
913

Interest rate swaps
 
2,605

 

 
2,605

 
3,558

 

 
3,558

Total
 
$
11,602

 
$
7,136

 
$
4,466

 
$
11,254

 
$
6,783

 
$
4,471


The Company uses the end of period when determining the timing of transfers between levels. During the three and nine months ended September 30, 2013 and 2012, there were no transfers between levels.
Short-Term Investments The Company has investments in certificates of deposit that are recorded at cost, which approximates fair value. Additionally, the Company has investments in U.S. dollar indexed bond funds that are classified as available-for-sale and stated at fair value. U.S. dollar indexed bond funds are reported at net asset value, which is the practical expedient for fair value as determined by banks where funds are held.
Assets Held in a Rabbi Trust / Deferred Compensation The fair value of the assets held in a rabbi trust is derived from investments in a mix of money market, fixed income and equity funds managed by Vanguard. The related deferred compensation liability is recorded at fair value.
Foreign Exchange Forward Contracts A substantial portion of the Company’s operations and revenues are international. As a result, changes in foreign exchange rates can create substantial foreign exchange gains and losses from the revaluation of non-

21

Table of Contents
DIEBOLD, INCORPORATED AND SUBSIDIARIES
FORM 10-Q as of September 30, 2013
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
(dollars in thousands, except per share amounts)


functional currency monetary assets and liabilities. The foreign exchange contracts are valued using the market approach based on observable market transactions of forward rates.
Interest Rate Swaps The Company has variable rate debt and is subject to fluctuations in interest-related cash flows due to changes in market interest rates. The Company’s policy is to periodically enter into derivative instruments designated as cash flow hedges to fix some portion of future variable rate-based interest expense. The Company has a pay-fixed receive-variable interest rate swap to hedge against changes in the LIBOR benchmark interest rate on a portion of the Company’s LIBOR-based borrowings. The fair value of the swap is determined using the income approach and is calculated based on LIBOR rates at the reporting date.
Assets and Liabilities Not Measured at Fair Value on a Recurring Basis
In addition to assets and liabilities that are measured at fair value on a recurring basis, the Company also measures certain assets and liabilities at fair value on a nonrecurring basis. Our non-financial assets, including goodwill, intangible assets and property, plant and equipment, are measured at fair value when there is an indication of impairment. These assets are recorded at fair value, determined using level 3 inputs, only when an impairment charge is recognized. Further details regarding the Company's goodwill other-than-annual-impairment review appears in note 9.
Assets and Liabilities Recorded at Carrying Value
The fair value of the Company’s cash and cash equivalents, trade receivables and accounts payable, approximates the carrying value due to the relative short maturity of these instruments. The fair value and carrying value of the Company’s debt instruments are summarized as follows:
 
 
September 30, 2013
 
December 31, 2012
 
 
Fair Value
 
Carrying
Value
 
Fair Value
 
Carrying
Value
Notes payable
 
$
26,773

 
$
26,773

 
$
34,212

 
$
34,212

Long-term debt
 
567,918

 
561,595

 
630,450

 
617,534

Total debt instruments
 
$
594,691

 
$
588,368

 
$
664,662

 
$
651,746

The fair value of the Company’s industrial development revenue bonds are measured using unadjusted quoted prices in active markets for identical assets categorized as level 1 inputs. The fair value of the Company’s current notes payable and credit facility debt instruments approximates the carrying value due to the relative short maturity of the revolving borrowings under these instruments. The fair values of the Company’s long-term senior notes were estimated using market observable inputs for the Company’s comparable peers with public debt, including quoted prices in active markets, market indices and interest rate measurements, considered level 2 inputs.

NOTE 17: SEGMENT INFORMATION
The Company’s segments are comprised of two sales channels: DNA and DI. The DNA segment sells and services financial and retail systems in the United States and Canada. The DI segment sells and services financial and retail systems over the remainder of the globe as well as voting and lottery solutions in Brazil.
The reconciliation between segment information and the condensed consolidated financial statements is disclosed. Revenue summaries by geographic area and service and product solutions are also disclosed. Certain information not routinely used in the management of the DNA and DI segments, not allocated back to the segments or information that is impractical to report is not shown. Items not allocated are as follows: investment income; interest expense; equity in the net income of investees accounted for by the equity method; income tax expense or benefit; foreign exchange gains and losses; and miscellaneous, net. The Company has reclassified the presentation of prior-year operating (loss) profit to conform to the current-year presentation due to changes in corporate allocations.








22

Table of Contents
DIEBOLD, INCORPORATED AND SUBSIDIARIES
FORM 10-Q as of September 30, 2013
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
(dollars in thousands, except per share amounts)


The following table presents information regarding the Company’s segments:
 
 
Three Months Ended
 
Nine Months Ended
 
 
September 30,
 
September 30,
 
 
2013
 
2012
 
2013
 
2012
DNA
 
 
 
 
 
 
 
 
Customer revenues
 
$
356,943

 
$
395,477

 
$
1,056,184

 
$
1,194,294

Intersegment revenues
 
21,265

 
14,737

 
60,157

 
41,638

Operating profit
 
28,295

 
22,424

 
35,831


113,020

Capital expenditures
 
4,192

 
8,262

 
15,391

 
20,862

Depreciation and amortization
 
16,253

 
12,940

 
46,583

 
40,055

Property, plant and equipment, at cost
 
418,562

 
465,570

 
418,562

 
465,570

Total assets
 
895,976

 
1,056,570

 
895,976

 
1,056,570

DI
 
 
 
 
 
 
 
 
Customer revenues
 
348,481

 
314,442

 
989,864

 
957,304

Intersegment revenues
 
3,784

 
5,414

 
19,485

 
39,893

Operating (loss) profit
 
(58,548
)
 
(1,399
)
 
(103,622
)

(724
)
Capital expenditures
 
3,300

 
6,925

 
10,257

 
14,994

Depreciation and amortization
 
5,638

 
5,174

 
17,502

 
16,854

Property, plant and equipment, at cost
 
185,137

 
184,287

 
185,137

 
184,287

Total assets
 
1,403,761

 
1,539,184

 
1,403,761

 
1,539,184

TOTAL
 
 
 
 
 
 
 
 
Customer revenues
 
705,424

 
709,919

 
2,046,048

 
2,151,598

Intersegment revenues
 
25,049

 
20,151

 
79,642

 
81,531

Operating (loss) profit
 
(30,253
)
 
21,025

 
(67,791
)
 
112,296

Capital expenditures
 
7,492

 
15,187

 
25,648

 
35,856

Depreciation and amortization
 
21,891

 
18,114

 
64,085

 
56,909

Property, plant and equipment, at cost
 
603,699